136 related articles for article (PubMed ID: 33140952)
1. Structural Fluctuations of Aromatic Residues in an Apo-Form Reveal Cryptic Binding Sites: Implications for Fragment-Based Drug Design.
Iida S; Nakamura HK; Mashimo T; Fukunishi Y
J Phys Chem B; 2020 Nov; 124(45):9977-9986. PubMed ID: 33140952
[TBL] [Abstract][Full Text] [Related]
2. Deciphering Cryptic Binding Sites on Proteins by Mixed-Solvent Molecular Dynamics.
Kimura SR; Hu HP; Ruvinsky AM; Sherman W; Favia AD
J Chem Inf Model; 2017 Jun; 57(6):1388-1401. PubMed ID: 28537745
[TBL] [Abstract][Full Text] [Related]
3. Exploring the structural origins of cryptic sites on proteins.
Beglov D; Hall DR; Wakefield AE; Luo L; Allen KN; Kozakov D; Whitty A; Vajda S
Proc Natl Acad Sci U S A; 2018 Apr; 115(15):E3416-E3425. PubMed ID: 29581267
[TBL] [Abstract][Full Text] [Related]
4. CryptoSite: Expanding the Druggable Proteome by Characterization and Prediction of Cryptic Binding Sites.
Cimermancic P; Weinkam P; Rettenmaier TJ; Bichmann L; Keedy DA; Woldeyes RA; Schneidman-Duhovny D; Demerdash ON; Mitchell JC; Wells JA; Fraser JS; Sali A
J Mol Biol; 2016 Feb; 428(4):709-719. PubMed ID: 26854760
[TBL] [Abstract][Full Text] [Related]
5. PlayMolecule CrypticScout: Predicting Protein Cryptic Sites Using Mixed-Solvent Molecular Simulations.
Martinez-Rosell G; Lovera S; Sands ZA; De Fabritiis G
J Chem Inf Model; 2020 Apr; 60(4):2314-2324. PubMed ID: 32175736
[TBL] [Abstract][Full Text] [Related]
6. Identification of Cryptic Binding Sites Using MixMD with Standard and Accelerated Molecular Dynamics.
Smith RD; Carlson HA
J Chem Inf Model; 2021 Mar; 61(3):1287-1299. PubMed ID: 33599485
[TBL] [Abstract][Full Text] [Related]
7. Structure-Based Analysis of Cryptic-Site Opening.
Sun Z; Wakefield AE; Kolossvary I; Beglov D; Vajda S
Structure; 2020 Feb; 28(2):223-235.e2. PubMed ID: 31810712
[TBL] [Abstract][Full Text] [Related]
8. Accelerated Ligand-Mapping Molecular Dynamics Simulations for the Detection of Recalcitrant Cryptic Pockets and Occluded Binding Sites.
Tze-Yang Ng J; Tan YS
J Chem Theory Comput; 2022 Mar; 18(3):1969-1981. PubMed ID: 35175753
[TBL] [Abstract][Full Text] [Related]
9. Computational sampling of a cryptic drug binding site in a protein receptor: explicit solvent molecular dynamics and inhibitor docking to p38 MAP kinase.
Frembgen-Kesner T; Elcock AH
J Mol Biol; 2006 May; 359(1):202-14. PubMed ID: 16616932
[TBL] [Abstract][Full Text] [Related]
10. Cosolvent-Enhanced Sampling and Unbiased Identification of Cryptic Pockets Suitable for Structure-Based Drug Design.
Schmidt D; Boehm M; McClendon CL; Torella R; Gohlke H
J Chem Theory Comput; 2019 May; 15(5):3331-3343. PubMed ID: 30998331
[TBL] [Abstract][Full Text] [Related]
11. Small Glycols Discover Cryptic Pockets on Proteins for Fragment-Based Approaches.
Bansia H; Mahanta P; Yennawar NH; Ramakumar S
J Chem Inf Model; 2021 Mar; 61(3):1322-1333. PubMed ID: 33570386
[TBL] [Abstract][Full Text] [Related]
12. Cryptic-site binding mechanism of medium-sized Bcl-xL inhibiting compounds elucidated by McMD-based dynamic docking simulations.
Bekker GJ; Fukuda I; Higo J; Fukunishi Y; Kamiya N
Sci Rep; 2021 Mar; 11(1):5046. PubMed ID: 33658550
[TBL] [Abstract][Full Text] [Related]
13. Investigating Cryptic Binding Sites by Molecular Dynamics Simulations.
Kuzmanic A; Bowman GR; Juarez-Jimenez J; Michel J; Gervasio FL
Acc Chem Res; 2020 Mar; 53(3):654-661. PubMed ID: 32134250
[TBL] [Abstract][Full Text] [Related]
14. Equilibrium fluctuations of a single folded protein reveal a multitude of potential cryptic allosteric sites.
Bowman GR; Geissler PL
Proc Natl Acad Sci U S A; 2012 Jul; 109(29):11681-6. PubMed ID: 22753506
[TBL] [Abstract][Full Text] [Related]
15. Understanding Cryptic Pocket Formation in Protein Targets by Enhanced Sampling Simulations.
Oleinikovas V; Saladino G; Cossins BP; Gervasio FL
J Am Chem Soc; 2016 Nov; 138(43):14257-14263. PubMed ID: 27726386
[TBL] [Abstract][Full Text] [Related]
16. Cryptic Pockets Repository through Pocket Dynamics Tracking and Metadynamics on Essential Dynamics Space: Applications to Mcl-1.
Benabderrahmane M; Bureau R; Voisin-Chiret AS; Santos JSO
J Chem Inf Model; 2021 Nov; 61(11):5581-5588. PubMed ID: 34748701
[TBL] [Abstract][Full Text] [Related]
17. Hidden allosteric sites and De-Novo drug design.
Rehman AU; Lu S; Khan AA; Khurshid B; Rasheed S; Wadood A; Zhang J
Expert Opin Drug Discov; 2022 Mar; 17(3):283-295. PubMed ID: 34933653
[TBL] [Abstract][Full Text] [Related]
18. Cryptic binding sites on proteins: definition, detection, and druggability.
Vajda S; Beglov D; Wakefield AE; Egbert M; Whitty A
Curr Opin Chem Biol; 2018 Jun; 44():1-8. PubMed ID: 29800865
[TBL] [Abstract][Full Text] [Related]
19. Are induced fit protein conformational changes caused by ligand-binding predictable? A molecular dynamics investigation.
Gao C; Desaphy J; Vieth M
J Comput Chem; 2017 Jun; 38(15):1229-1237. PubMed ID: 28419481
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of striatal-enriched protein tyrosine phosphatase by targeting computationally revealed cryptic pockets.
Hou X; Sun JP; Ge L; Liang X; Li K; Zhang Y; Fang H
Eur J Med Chem; 2020 Mar; 190():112131. PubMed ID: 32078861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
